DOSSIER · 13F-HR · Q2 2026

Odyssean, LLC

$615M in tracked AUM across 485 positions as of Q2 2026.

OL
CIK 0002092853 · last filed Jun 30, 2026
Total AUM
$615M
as of Q2 2026
Holdings
485
positions
Whale Score
45
45
tracked
Activity
no data
changes this Q
AI Analysis · Q2 2026

Odyssean, LLC filed its latest 13F-HR for Q2 2026. See the latest holdings and position changes below.

Quarter at a glance — Q2 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q2 2026.

#HoldingValueSharesWeight
01
RARE
ULTRAGENYX PHARMACEUTICAL IN
$4M122K0.7%
02
KYMR
KYMERA THERAPEUTICS INC
$4M34K0.6%
03
IDYA
IDEAYA BIOSCIENCES INC
$4M103K0.6%
04
PCVX
VAXCYTE INC
$4M63K0.6%
05
AFRM
AFFIRM HLDGS INC
$4M44K0.6%
06
CLDX
CELLDEX THERAPEUTICS INC NEW
$4M95K0.6%
07
LOAR
LOAR HOLDINGS INC
$4M44K0.6%
08
MIRM
MIRUM PHARMACEUTICALS INC
$4M30K0.6%
09
DASH
DOORDASH INC
$3M19K0.6%
10
KRYS
KRYSTAL BIOTECH INC
$3M9K0.6%

Filing history

2026Q2Jun 30
$615M 124.5%
485 positionsView →
2026Q1Mar 31
$274M 96.7%
418 positionsView →
2025Q4Dec 31
$139M
254 positionsView →